The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
The company has extended its full co-operation and support to the officials of the Income Tax Department
The facility will have a capacity to manufacture upto 3 million tubes monthly
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Metoprolol is used with or without other medications to treat high blood pressure (hypertension).
Marksans will continue to supply existing products until the end of 2023 to Teva's affiliates, ensuring high-quality standards
Apremilast Tablets, 10 mg, 20 mg, and 30 mg is a generic equivalent of reference listed drug (RLD) OTEZLA of Celgene.
Bourgoin early development hub broadens offerings for oral solid dose formulations
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
Subscribe To Our Newsletter & Stay Updated
